Table 7 of
Micheal, Mol Vis 2013; 19:441-xxx.
Table 7. MMP-9 SNPs genotype frequencies with respect to gender in POAG and PACG patients and unaffected controls
Males | Females | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Controls n=71 (%) | POAG n=78 (%) | p (χ2) | PACG n=40 (%) | p (χ2) | Controls n=47 (%) | POAG n=34 (%) | p (χ2) | PACG n=42 (%) | p (χ2) | |
MMP-9 = c.-1562C>T | ||||||||||
CC | 42 (59.2) | 49 (62.8) | 0.43 (1.68) | 26 (65.0) | 0.22 (2.97) | 32 (68.1) | 21 (61.8) | 0.32 (2.25) | 30 (71.4) | 0.86 (0.28) |
CT | 24 (33.8) | 27 (34.6) | 14 (35.0) | 13 (27.7) | 13 (38.2) | 11 (26.2) | ||||
TT | 5 (7.0) | 2 (2.6) | 0 (0.00) | 2 (4.2) | 0 (0.00) | 1 (2.4) | ||||
MMP-9 = c.836A>G | ||||||||||
AA | 24 (33.8) | 21 (26.9) | 0.28 (2.51) | 5 (12.5) | 0.009 (9.21) | 16 (34.0) | 5 (14.7) | 0.08 (4.88) | 10 (23.8) | 0.14 (3.86) |
AG | 33 (46.5) | 33 (42.3) | 18 (45.0) | 20 (42.6) | 15 (44.1) | 14 (33.3) | ||||
GG | 14 (19.7) | 24 (30.8) | 17 (42.5) | 11 (23.4) | 14 (41.2) | 18 (42.9) |